Bill > HR8454

This bill, the Medical Marijuana and Cannabidiol Research Expansion Act, aims to expand research on cannabidiol and marijuana for medical purposes. The key provisions include: 1. Streamlining the registration process for researchers to conduct studies on marijuana and cannabidiol, including faster application approvals and more flexibility to amend research protocols. 2. Allowing covered higher education institutions, practitioners, and manufacturers to manufacture, distribute, dispense, or possess marijuana or cannabidiol for the purpose of medical research for drug development or subsequent commercial production. 3. Requiring the Attorney General to register applicants to manufacture or distribute cannabidiol or marijuana for the commercial production of FDA-approved drugs containing or derived from marijuana. 4. Clarifying that it is not a violation for state-licensed physicians to discuss the potential harms and benefits of marijuana and its derivatives with patients or their legal guardians. 5. Directing the Secretary of Health and Human Services to submit a report to Congress on the potential therapeutic effects and public health impacts of cannabidiol and marijuana, as well as the barriers to research in states that have legalized these substances. Overall, the bill aims to facilitate and expand medical research on marijuana and its components like cannabidiol to better understand their potential therapeutic uses and public health implications.

Business and Industry

https://www.congress.gov/bill/117th-congress/house-bill/8454/all-info